Radiopharmaceuticals Market Outlook to 2021, Update 2017 – Investment Trends, Regulations and Company Profiles & Forecast
Aug 14, 2017
Research analysts forecast the Global Radiopharmaceuticals Market to grow at a CAGR of 9.02% during the period 2017-2021.
Dallas, United States - August 14, 2017 /MarketersMedia/ —
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand for radiopharmaceuticals for both therapeutic and diagnostic segments. Some of the other major segments finding the huge application of radiopharmaceuticals are neurology, cardiology, and thyroid disorder treatment.
Request sample copy of the report at:
http://www.orbisresearch.com/contacts/request-sample/379325
The report covers the present scenario and the growth prospects of the global radiopharmaceuticals market for 2017-2021. To calculate the market size, the report considers the sales of radiopharmaceuticals.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Research report, Global Radiopharmaceuticals Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Bayer,
Cardinal Health,
GE Healthcare,
Lantheus Medical Imaging
Other prominent vendors
ABT Molecular Imaging
Advanced Accelerator Applications
Algeta
Eczacibasi-Monrol Nuclear Products
FUJIFILM Holdings
Isologic Innovative Radiopharmaceuticals
Nordion
Piramal Imaging
RadioMedix
Triad Isotopes
Market driver
Rising burden of the neurological disorders
For a full, detailed list, view our report
Market challenge
Shortage of radioisotopes
For a full, detailed list, view our report
Market trend
Partnerships for development of radiopharmaceuticals
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Companies Mentioned:
Bayer, Cardinal Health, GE Healthcare, Lantheus Medical Imaging, ABT Molecular Imaging, Advanced Accelerator Applications, Algeta, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, Isologic Innovative Radiopharmaceuticals, Nordion, Piramal Imaging, RadioMedix, and Triad Isotopes.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/379325
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Contact Info:
Name: Hector Costello
Email: [email protected]
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A.
Phone: +1 (214) 884-6817
For more information, please visit http://www.orbisresearch.com/reports/index/global-cancer-gene-therapy-market-2017-2021
Source: MarketersMedia
Release ID: 228710
More News
A.I. and Its Dangers Are Embedded In the Midterm Elections
The midterms are the first elections in which artificial intelligence is integrated into every major social media platform. Efforts to blunt its harms are uneven.
PHP Security Flaw Sets Off Global Rush to Patch, Leaving Websites Offline
Governments and businesses around the world scrambled to prevent hackers from exploiting a vulnerability in PHP, a popular programming language.
When Do Rules on Historic Preservation Go Too Far?
Saratoga Springs, N.Y., stands out for its preservation efforts. But some say strict designs have become a burden for residents.
'I wasn't thinking straight' says five jobs civil servant
Kashim Chowdhury is accused of fraudulently juggling multiple public sector jobs.
Barclays cutting 5,000 jobs as it increases reliance on AI
The bank says it is using more AI leading to a 5% reduction in its workforce.
Tank barrel production returns to UK after 20 years
The defence secretary says the UK is "back in the business of making weapons" for its armed forces.
The Briefing Room
After mass protests and violence, what will persuade the French to accept economic reform?
Barclays to Cut 5,000 Jobs in A.I.-Driven Push to Lower Costs
The move is the latest illustration of a company saying it believes it can be more efficient with fewer workers because of artificial intelligence.
Zuckerberg’s Big Deal to Stay in California
The agreement that Mark Zuckerberg, Meta’s chief executive, cut to stay in California underscores businesses’ fears about a major tax proposal.
What is PHP and why did it spark a global cyber-security scramble?
AI uncovered long-hidden programming flaws, triggering a rare global cyber-security response.
China outlines progress in high-quality trade & investment development
Looking ahead to the 15th Five-Year Plan period (2026–2030), China will seek to strengthen the three pillars of trade: goods, services and digital trade. It will also continue to expand high-standard opening-up, deepen two-way investment cooperation and strengthen international economic and trade ties.
China is in a good position to develop its pension framework
China is still at an early stage in developing its third-pillar pension system, giving it an opportunity to learn from other countries' experiences, said Simon Richards, head of Insurance Solutions at Insight Investment, a subsidiary of BNY Investments, in an interview with CGTN at the 2026 Financial Street Forum.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.